Forte Biosciences (FBRX) Shareholder's Equity Growth (3y) (2019 - 2026)
Forte Biosciences (FBRX) Shareholder's Equity Growth (3y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Forte Biosciences |
70.77 Mn |
12.55 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
8.51% |
| Dec 31, 2025 |
16.25% |
| Sep 30, 2025 |
25.22% |
| Jun 30, 2025 |
37.17% |
| Mar 31, 2025 |
-1.37% |
| Dec 31, 2024 |
8.10% |
| Sep 30, 2024 |
-40.13% |
| Jun 30, 2024 |
-30.22% |
| Mar 31, 2024 |
-19.36% |
| Dec 31, 2023 |
-15.72% |
| Sep 30, 2023 |
25.75% |
| Jun 30, 2023 |
0.01% |
| Mar 31, 2023 |
90.06% |
| Dec 31, 2022 |
116.44% |
| Sep 30, 2022 |
147.91% |
| Jun 30, 2022 |
157.10% |
| Mar 31, 2022 |
183.85% |
| Dec 31, 2021 |
288.09% |
| Sep 30, 2021 |
-2.89% |
| Jun 30, 2021 |
2.69% |
